Skip to content

Alprazolam

Published: July 22, 2026Updated: July 22, 2026

Alprazolam is a benzodiazepine medication primarily prescribed for anxiety and panic disorders. It works by enhancing the effects of GABA, a calming neurotransmitter in the brain, producing sedative and anxiolytic effects.

Quick summary

Alprazolam is a short-acting benzodiazepine used to treat anxiety and panic disorders by enhancing GABA activity in the brain.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 22, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
N05BA12
Generic
Alprazolam
Class
benzodiazepine
Brands
Xanax
Availability
controlled
Pregnancy
D
Lactation
unsafe
Half-life (h)
12
Onset (min)
15
Duration (h)
6
Routes
oral
Forms
tablet
Regions
CN, US, EU, JP
Monitoring
dependence, respiratory-depression

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
0.25mg to 0.5mg three times daily
Maximum
consult physician
Frequency
every 8 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
0.125mg to 0.25mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
0.25mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity, though risk significantly increases with co-ingestion of other CNS depressants like alcohol
Chronic overdose: Prolonged high-dose use can lead to accumulation, tolerance, and severe CNS depression
Immediate actions
Supportive care, airway management, monitoring of respiratory and cardiac status
Antidote
Flumazenil(Effective in reversing benzodiazepine sedation but must be used cautiously due to risk of seizures in dependent patients)
Poison Control: 1-800-222-1222

Special Populations

8 groups
✗

pregnancy

first trimester
unsafe
FDA Category
D
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits significantly outweigh risks

Monitor

regular fetal monitoring and assessment of neonatal withdrawal

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
D
Dose Adjustment

avoid if possible

Key Recommendations

avoid use near delivery due to risk of neonatal sedation and withdrawal

Monitor

monitor newborn for respiratory depression, sedation, and withdrawal symptoms

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
N
Dose Adjustment

avoid during breastfeeding

Key Recommendations

do not breastfeed during alprazolam therapy due to infant exposure

Monitor

monitor infant for excessive sedation, poor feeding, and developmental changes

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly 65 plus
caution
FDA Category
N
Dose Adjustment

reduce initial dose by 50%

Key Recommendations

start with lowest effective dose, use with extreme caution due to increased sensitivity

Monitor

monitor for excessive sedation, dizziness, falls, and cognitive impairment

Use with caution and monitor for adverse effects.

✗

pediatric_age

children adolescents
contraindicated
FDA Category
N
Dose Adjustment

not recommended for pediatric patients

Key Recommendations

not approved for use in patients under 18 years of age

Monitor

not applicable - avoid use

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

renal_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

no major dose adjustment needed but use with caution

Key Recommendations

use with caution, monitor for excessive sedation

Monitor

monitor renal function and sedation levels

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

reduce dose by 50%

Key Recommendations

use with caution due to metabolism in liver, reduce initial dose

Monitor

monitor liver function and sedation levels

Use with caution and monitor for adverse effects.

✗

alcohol_users

concurrent alcohol use
contraindicated
FDA Category
N
Dose Adjustment

absolutely contraindicated

Key Recommendations

do not use alprazolam with alcohol under any circumstances

Monitor

not applicable - avoid concomitant use

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1981

Year Alprazolam was first approved for medical use in the United States

drug_classWHO
2023

Drug class

Value:Benzodiazepine

Alprazolam belongs to the benzodiazepine class of central nervous system depressants

usageFDA
2023

Common uses

Value:Anxiety disorders, panic disorder, depression-related anxiety

Primary therapeutic indications for Alprazolam

regulationDEA
2023

Controlled substance schedule

Value:Schedule IV

Federal controlled substance classification in the United States

Treats generalized anxiety disorder (GAD), panic disorder with or without agoraphobia, and short-term anxiety relief. May occasionally be used for insomnia associated with anxiety.

Binds to benzodiazepine sites on GABA-A receptors, increasing the frequency of chloride channel opening when GABA binds. This enhances inhibitory signaling, reducing neuronal excitability and producing calming effects.

Schedule IV controlled substance with risk of dependence, tolerance, and withdrawal symptoms with prolonged use. May cause drowsiness, cognitive impairment, and respiratory depression—particularly risky combined with alcohol, opioids, or other CNS depressants. Short half-life (~11-12 hours) may lead to rebound anxiety between doses. Not recommended for long-term use; discontinuation requires gradual tapering under medical supervision.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 22, 2026. · Read our editorial policy